Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Diabetes Incidence
100%
α-galactosylceramide (α-GalCer)
100%
Non-obese Diabetic Mice
100%
Bacteroides Fragilis
100%
Probiotic Therapy
100%
B. Fragilis
100%
Splenocytes
37%
Type I Diabetes
25%
Type 1 Diabetes Mellitus (T1DM)
25%
Adoptive Transfer
25%
NKT Cells
25%
M2 Macrophages
25%
GalCer
25%
Invariant NKT Cells
25%
Flow Cytometry
12%
Immune Response
12%
Mediating Effect
12%
Protective Effect
12%
Inflammatory Mediators
12%
Insulitis
12%
Young Female
12%
Early Treatment
12%
Pancreas
12%
Individuals at Risk
12%
CD4+
12%
Islet
12%
Severe Combined Immunodeficiency
12%
Serum Insulin
12%
Non-obese Diabetic
12%
Culture Media
12%
Immunodeficient Mice
12%
T Cell Subpopulations
12%
Growing Media
12%
Systemic Immunosuppression
12%
Probiotic Potential
12%
Mouse Splenocytes
12%
Multiplex Technology
12%
Invariant Natural Killer T Cells
12%
Killing Bacteria
12%
Islet Pathology
12%
Diabetes Onset
12%
Immunosuppressive Capacity
12%
Immunology and Microbiology
Nonobese Diabetic Mouse
100%
Probiotic
100%
Bacteroides fragilis
100%
Natural Killer T Cell
71%
Splenocyte
57%
M2 Macrophages
28%
Mediator
14%
Immune Response
14%
Insulin Blood Level
14%
CD4
14%
Immunosuppression
14%
Pancreas
14%
SCID Mouse
14%
Cell Population
14%
Immunosuppressive Drug
14%
Bacterium
14%